샘플 요청 목록

 카트 문의
시장보고서
상품코드
1763205

세계의 HCS 소프트웨어 및 서비스 시장

HCS Software and Services
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 HCS 소프트웨어 및 서비스 시장은 2030년까지 19억 달러에 달할 전망

2024년에 14억 달러로 추정되는 세계의 HCS 소프트웨어 및 서비스 시장은 2024-2030년에 CAGR 5.6%로 성장하며, 2030년에는 19억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 HCS 서비스는 CAGR 6.0%를 기록하며, 분석 기간 종료시에는 15억 달러에 달할 것으로 예측됩니다. HCS 소프트웨어 분야의 성장률은 분석 기간 중 CAGR 4.7%로 추정됩니다.

미국 시장은 3억 8,240만 달러로 추정, 중국은 CAGR 5.1%로 성장 예측

미국의 HCS 소프트웨어 및 서비스 시장은 2024년에 3억 8,240만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 5.1%로 2030년까지 2억 9,980만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.1%와 4.6%로 예측됩니다. 유럽에서는 독일이 CAGR 4.2%로 성장할 것으로 예측됩니다.

세계의 HCS 소프트웨어 및 서비스 시장 - 주요 동향과 촉진요인 정리

고함량 스크리닝(HCS) 기술은 어떻게 신약개발에 혁명을 가져올 수 있는가?

고함량 스크리닝(HCS) 소프트웨어 및 서비스는 자동화된 이미징과 데이터 처리를 통해 복잡한 세포 분석을 가능하게 함으로써 신약개발에 혁신을 가져오고 있습니다. 초기 약물 개발에 있으며, 매우 중요한 역할을 할 수 있습니다. HCS 소프트웨어는 고급 이미지 분석을 통합하여 약물 후보물질을 정확하게 식별할 수 있으며, 개발 프로세스의 시간과 비용을 절감할 수 있습니다. 제약업계가 정밀하고 높은 처리량의 스크리닝 방법에 점점 더 중점을 두고 있는 가운데, HCS 기술은 현대 신약개발의 초석이 되고 있습니다.

맞춤형 의료에서 HCS 수요가 증가하는 이유

환자 개개인프로파일에 따라 치료를 조정하는 맞춤의료의 부상으로 HCS 솔루션에 대한 수요가 증가하고 있습니다. 맞춤 치료는 특정 화합물이 다른 세포종과 어떻게 상호 작용하는지에 대한 깊은 이해가 필요하며, HCS는 이러한 상호 작용에 대한 심층적인 인사이트를 제공합니다. 이 기술은 특히 종양학에서 가치가 있으며, 다양한 치료가 암세포에 어떤 영향을 미치는지 이해하는 데 도움이 됩니다. HCS 소프트웨어는 세포의 반응에 대한 정확한 데이터를 제공함으로써 맞춤형 의료 구상을 지원하고 약물 개발을 보다 목표 지향적이고 효과적으로 만들 수 있습니다.

기술 발전은 HCS의 능력을 어떻게 향상시키고 있는가?

AI를 활용한 이미지 분석과 머신러닝 알고리즘을 포함한 HCS 기술의 발전으로 세포 분석의 정확도와 속도가 향상되고 있으며, AI를 활용한 HCS 소프트웨어는 세포의 패턴과 이상을 자동으로 식별할 수 있으며, 보다 빠른 데이터 분석이 가능해져 연구자들이 더 많은 화합물을 더 짧은 시간 내에 스크리닝할 수 있습니다. 더 많은 화합물을 단기간에 스크리닝할 수 있습니다. 또한 클라우드 기반 솔루션을 통해 원격 액세스 및 데이터 공유가 가능해져 HCS 소프트웨어가 공동 연구를 통해 범용성을 확보할 수 있게 되었습니다. 이러한 발전으로 인해 HCS는 신약 개발의 효율성을 높이고, 연구기관과 제약회사에 점점 더 가치 있는 툴이 되고 있습니다.

HCS 소프트웨어 및 서비스 시장의 성장 원동력은?

HCS 소프트웨어 및 서비스 시장의 성장은 신약개발 솔루션에 대한 수요 증가, 맞춤형 의료의 발전, 기술 혁신 등 여러 요인에 의해 이루어지고 있습니다. 제약사들은 신약 개발의 효율성과 스크리닝 정확도 향상을 위해 HCS 기술에 투자하고 있습니다. 또한 맞춤형 의료에 대한 관심도 HCS 소프트웨어가 표적 치료법 개발에 필수적인 데이터를 제공한다는 점에서 수요를 촉진하고 있습니다. 또한 기술 발전, 특히 AI와 클라우드 기반 플랫폼은 HCS의 기능을 강화하여 현대 의약품 연구에 필수적인 툴로 자리매김하고 있습니다. 이러한 요인을 종합하면 HCS 소프트웨어 및 서비스 시장은 헬스케어 및 신약 개발의 진화하는 요구에 부응하여 성장할 것으로 예측됩니다.

부문

제품 유형(HCS 서비스, HCS 소프트웨어), 용도(화합물 개요, 프라이머리 & 세컨더리 스크리닝, 타겟 식별 & 밸리데이션, 기타 용도), 최종 용도(바이오테크놀러지 기업, 교육 기관, 정부기관, 기타 최종 용도)

조사 대상 기업의 예

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Thorlabs Inc.
  • Yokogawa Electric Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.07.14

Global HCS Software and Services Market to Reach US$1.9 Billion by 2030

The global market for HCS Software and Services estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. HCS Services, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the HCS Software segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$382.4 Million While China is Forecast to Grow at 5.1% CAGR

The HCS Software and Services market in the U.S. is estimated at US$382.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$299.8 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global HCS Software and Services Market - Key Trends & Drivers Summarized

How Is High-Content Screening (HCS) Technology Revolutionizing Drug Discovery?

High-content screening (HCS) software and services are transforming drug discovery by enabling complex cellular analyses through automated imaging and data processing. HCS technology allows researchers to study the effects of compounds on cellular behavior at a high resolution, making it valuable in early drug development. By integrating advanced image analysis, HCS software enables the identification of drug candidates with high accuracy, reducing time and costs in the development process. With the pharmaceutical industry increasingly focused on precise, high-throughput screening methods, HCS technology is becoming a cornerstone in modern drug discovery.

Why Is Demand for HCS Growing in Personalized Medicine?

The rise of personalized medicine, which tailors treatments based on individual patient profiles, is boosting demand for HCS solutions. Personalized treatments require a deep understanding of how specific compounds interact with different cell types, and HCS provides detailed insights into these interactions. The technology is particularly valuable in oncology, where it aids in understanding how different treatments affect cancer cells. By providing precise data on cellular responses, HCS software supports personalized medicine initiatives, making drug development more targeted and effective.

How Are Technological Advancements Enhancing HCS Capabilities?

Advancements in HCS technology, including AI-powered image analysis and machine learning algorithms, are enhancing the accuracy and speed of cellular analysis. AI-driven HCS software can automatically identify cellular patterns and anomalies, supporting faster data analysis and enabling researchers to screen more compounds within a shorter timeframe. Additionally, cloud-based solutions are allowing for remote access and data sharing, making HCS software more versatile for collaboration. These advancements are driving the efficiency of HCS in drug discovery, making it an increasingly valuable tool for research institutions and pharmaceutical companies.

What Drives the Growth of the HCS Software and Services Market?

The growth in the HCS software and services market is driven by several factors, including increased demand for drug discovery solutions, advancements in personalized medicine, and technological innovations. Pharmaceutical companies are investing in HCS technology to streamline drug development and improve screening accuracy. The focus on personalized medicine is also fueling demand, as HCS software provides essential data for developing targeted treatments. Furthermore, technological advancements, particularly AI and cloud-based platforms, are enhancing HCS capabilities, making it an indispensable tool in modern drug research. These factors collectively position the HCS software and services market for growth as it addresses evolving needs in healthcare and drug discovery.

SCOPE OF STUDY:

The report analyzes the HCS Software and Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (HCS Services, HCS Software); Application (Compound Profiling, Primary & Secondary Screening, Target Identification & Validation, Other Applications); End-Use (Biotech Companies, Educational Institutions, Government Organizations, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Thorlabs Inc.
  • Yokogawa Electric Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • HCS Software and Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Adoption of High-Throughput Screening in Drug Discovery
    • Growth in Demand for Automated HCS Solutions for Precision Medicine
    • Technological Advancements in HCS Imaging and Data Analysis Software
    • Expansion of HCS Applications in Oncology and Neurology Research
    • Increased Use of AI in HCS for Predictive Modeling and Data Analysis
    • Development of Cloud-Based HCS Solutions for Real-Time Access
    • Growth of HCS in Stem Cell Research and Regenerative Medicine
    • Higher Demand for Multi-Parameter Screening Solutions in HCS
    • Expansion of Pharmaceutical R&D Programs Using HCS
    • Rising Demand for Cost-Effective and High-Precision Screening Technologies
    • Growing Interest in HCS for Personalized Medicine Development
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World HCS Software and Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for HCS Software and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for HCS Software and Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for HCS Software and Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for HCS Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for HCS Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for HCS Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for HCS Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for HCS Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for HCS Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Primary & Secondary Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Compound Profiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Compound Profiling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Compound Profiling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Educational Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Educational Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Educational Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Government Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Government Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for HCS Software and Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for HCS Software and Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for HCS Software and Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • HCS Software and Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for HCS Software and Services by Product Type - HCS Services and HCS Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for HCS Software and Services by Product Type - HCS Services and HCS Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for HCS Software and Services by Product Type - Percentage Breakdown of Value Sales for HCS Services and HCS Software for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for HCS Software and Services by Application - Primary & Secondary Screening, Target Identification & Validation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for HCS Software and Services by Application - Percentage Breakdown of Value Sales for Primary & Secondary Screening, Target Identification & Validation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for HCS Software and Services by End-Use - Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for HCS Software and Services by End-Use - Percentage Breakdown of Value Sales for Compound Profiling, Biotech Companies, Educational Institutions, Government Organizations and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제